Handelsbanken Fonder’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
4,400
-400
| -8% | -$121K | ﹤0.01% | 833 |
|
|
2025
Q1 | $1.59M | Sell |
4,800
-28,000
| -85% | -$9.28M | 0.01% | 742 |
|
|
2024
Q4 | $10.1M | Buy |
32,800
+300
| +0.9% | +$92.6K | 0.04% | 357 |
|
|
2024
Q3 | $6.9M | Buy |
32,500
+900
| +3% | +$191K | 0.03% | 396 |
|
|
2024
Q2 | $8.85M | Buy |
31,600
+9,300
| +42% | +$2.61M | 0.04% | 356 |
|
|
2024
Q1 | $5.96M | Buy |
22,300
+19,000
| +576% | +$5.07M | 0.03% | 423 |
|
|
2023
Q4 | $764K | Buy |
3,300
+500
| +18% | +$116K | ﹤0.01% | 927 |
|
|
2023
Q3 | $409K | Hold |
2,800
| – | – | ﹤0.01% | 1151 |
|
|
2023
Q2 | $647K | Sell |
2,800
-1,000
| -26% | -$231K | ﹤0.01% | 943 |
|
|
2023
Q1 | $921K | Hold |
3,800
| – | – | 0.01% | 726 |
|
|
2022
Q4 | $1.1M | Hold |
3,800
| – | – | 0.01% | 624 |
|
|
2022
Q3 | $247K | Hold |
3,800
| – | – | ﹤0.01% | 1351 |
|
|
2022
Q2 | $272K | Hold |
3,800
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q1 | $373K | Hold |
3,800
| – | – | ﹤0.01% | 1393 |
|
|
2021
Q4 | $322K | Buy |
3,800
+1,100
| +41% | +$93.2K | ﹤0.01% | 1593 |
|
|
2021
Q3 | $215K | Hold |
2,700
| – | – | ﹤0.01% | 1646 |
|
|
2021
Q2 | $263K | Buy |
2,700
+300
| +13% | +$29.2K | ﹤0.01% | 1661 |
|
|
2021
Q1 | $281K | Hold |
2,400
| – | – | ﹤0.01% | 1465 |
|
|
2020
Q4 | $267K | Buy |
+2,400
| New | +$267K | ﹤0.01% | 1452 |
|